We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
301
Lincoln National
LNC
$8.81B
$620K 0.1%
+12,331
New +$524K
KMB icon
302
Kimberly-Clark
KMB
$36.5B
$618K 0.1%
+4,581
New +$641K
MERC icon
303
Mercer International
MERC
$39.8M
$618K 0.1%
60,253
-8,640
-13% -$69.1K
MLKN icon
304
MillerKnoll
MLKN
$1.67B
$617K 0.1%
+18,256
New +$636K
UFCS icon
305
United Fire Group
UFCS
$1.4B
$615K 0.1%
24,513
+4,909
+25% +$112K
EVFM
306
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$615K 0.1%
17,020
+12,576
+283% +$455K
CDW icon
307
CDW
CDW
$17B
$613K 0.1%
4,653
+801
+21% +$105K
WTM icon
308
White Mountains Insurance
WTM
$5.13B
$613K 0.1%
613
-429
-41% -$404K
CMRX
309
DELISTED
Chimerix, Inc.
CMRX
$613K 0.1%
126,907
-10,742
-8% -$38.9K
SXI icon
310
Standex International
SXI
$4.12B
$611K 0.1%
+7,880
New +$562K
FN icon
311
Fabrinet
FN
$20.1B
$610K 0.1%
+7,864
New +$535K
CPLG
312
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$610K 0.1%
88,642
+10,027
+13% +$60.9K
COOP
313
DELISTED
Mr. Cooper
COOP
$609K 0.1%
+19,624
New +$503K
MXL icon
314
MaxLinear
MXL
$6.8B
$607K 0.1%
15,897
-17,146
-52% -$498K
SASR
315
DELISTED
Sandy Spring Bancorp Inc
SASR
$607K 0.1%
+18,863
New +$538K
WTFC icon
316
Wintrust Financial
WTFC
$10.7B
$605K 0.1%
9,909
-9,473
-49% -$510K
CPF icon
317
Central Pacific Financial
CPF
$1B
$604K 0.1%
31,763
+5,385
+20% +$87.7K
PCSB
318
DELISTED
PCSB Financial Corporation
PCSB
$604K 0.1%
37,874
+19,120
+102% +$283K
MDC
319
DELISTED
M.D.C. Holdings, Inc.
MDC
$602K 0.1%
+13,375
New +$596K
FRC
320
DELISTED
First Republic Bank
FRC
$602K 0.1%
+4,100
New +$534K
PJT icon
321
PJT Partners
PJT
$4.38B
$601K 0.1%
+7,981
New +$562K
JAX
322
DELISTED
J. Alexander's Holdings, Inc.
JAX
$599K 0.1%
82,191
-24,634
-23% -$157K
CME icon
323
CME Group
CME
$94.8B
$598K 0.1%
3,286
+1,522
+86% +$259K
RMBS icon
324
Rambus
RMBS
$11B
$597K 0.1%
+34,204
New +$537K
DKNG icon
325
DraftKings
DKNG
$11.9B
$595K 0.1%
12,772
+9,356
+274% +$445K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.